 |
| Opinion of the Scientific Committee on Cosmetic and non-food products intended for Consumers concerning 2-ethylhexyl salicylate adopted by the plenary session of the SCCNFP of 21 January 1998 |  |
|  |
 |  |
| |
Summary sheet on Commission
Review (ref. XXIV/1860/95, rev.
1/98)
Ingredient :
2-ethylhexyl salicylate
CAS n° : RN-118-60-5
Function and maximum use
concentration : UV filter, 5 %
Assessment of acute
toxicity (oral) : low.
Assessment of
sub-chronic toxicity (dermal
and oral) :
- Low toxicity with a
high no effect level
Test for irritation and
corrosivity : negative
- Repeated exposure to
the compound in man, in the
course of two separate
experiments, showed no adverse
effects
Test for photo-toxicity
and photo-contact allergy in
man were negative.
Tests for mutagenicity,
clastogenicity,
photo-mutagenicity and
photo-clastogenicity, using
bacterial and tissue culture
test systems, were negative
Tests for percutaneous
absorption in the course of 6
experiments using human skin ex
vitro showed very low
absorption. The margin of
safety was accordingly judged
to be very high.
The compound had been
the subject of provisional
authorisation for a substantial
period of time, and no adverse
effects in use had been
reported.
Classification: 1 (See
"Classification of Substances")
Statement on the
toxicological evaluation
The SCCNFP is the
scientific advisory body to the
European Commission in matters
of consumer protection with
respect to cosmetics and
non-food products intended for
consumers.
The Commission's general
policy regarding research on
animals supports the
development of alternative
methods to replace or to reduce
animal testing when possible.
In this context, the SCCNFP has
a specific working group on
alternatives to animal testing
which, in co-operation with
other Commission services such
as ECVAM (European Centre for
Validation of Alternative
Methods), evaluates these
methods.
SCCNFP opinions include
evaluations of experiments
using laboratory animals; such
tests are conducted in
accordance with all legal
provisions and preferably under
chemical law regulations. Only
in cases where no alternative
method is available will such
tests be evaluated and the
resulting data accepted, in
order to meet the fundamental
requirements of the protection
of consumer health.
| |
 |  |  |
|
|